NCT00570401 2016-01-22
Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
3 trialsNCT01491633 2014-07-15
Dasatinib in Advanced Squamous Cell Lung Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00858403 2014-01-15
Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated